Genetic Technologies (Australia) Probability of Future Stock Price Finishing Under 0.0004
| GTG Stock | 0.04 0.00 0.00% |
Genetic |
Genetic Technologies Target Price Odds to finish below 0.0004
The tendency of Genetic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.0004 or more in 90 days |
| 0.04 | 90 days | 0.0004 | near 1 |
Based on a normal probability distribution, the odds of Genetic Technologies to drop to 0.0004 or more in 90 days from now is near 1 (This Genetic Technologies probability density function shows the probability of Genetic Stock to fall within a particular range of prices over 90 days) . Probability of Genetic Technologies price to stay between 0.0004 and its current price of 0.039 at the end of the 90-day period is about 19.15 .
Assuming the 90 days trading horizon Genetic Technologies has a beta of -0.0723. This usually indicates as returns on the benchmark increase, returns on holding Genetic Technologies are expected to decrease at a much lower rate. During a bear market, however, Genetic Technologies is likely to outperform the market. Additionally Genetic Technologies has an alpha of 0.0059, implying that it can generate a 0.005878 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Genetic Technologies Price Density |
| Price |
Predictive Modules for Genetic Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genetic Technologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Genetic Technologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genetic Technologies is not an exception. The market had few large corrections towards the Genetic Technologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genetic Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genetic Technologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | -0.07 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | -0.03 |
Genetic Technologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genetic Technologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genetic Technologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Genetic Technologies generated a negative expected return over the last 90 days | |
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies has high historical volatility and very poor performance | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies generates negative cash flow from operations | |
| Latest headline from news.google.com: Genetic Technologies Enters Voluntary Administration - TipRanks |
Genetic Technologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genetic Stock often depends not only on the future outlook of the current and potential Genetic Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genetic Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132.2 M | |
| Cash And Short Term Investments | 1 M |
Genetic Technologies Technical Analysis
Genetic Technologies' future price can be derived by breaking down and analyzing its technical indicators over time. Genetic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genetic Technologies. In general, you should focus on analyzing Genetic Stock price patterns and their correlations with different microeconomic environments and drivers.
Genetic Technologies Predictive Forecast Models
Genetic Technologies' time-series forecasting models is one of many Genetic Technologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genetic Technologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Genetic Technologies
Checking the ongoing alerts about Genetic Technologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Genetic Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Genetic Technologies generated a negative expected return over the last 90 days | |
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies has high historical volatility and very poor performance | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies generates negative cash flow from operations | |
| Latest headline from news.google.com: Genetic Technologies Enters Voluntary Administration - TipRanks |
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.